Roberto Lara
8 SlideShares 0 Clipboards 6 Followers 0 Followings
Personal Information
Organization / Workplace
Montreal, Canada Area Canada
Occupation
Director, Business Development - Oncology
Industry
Medical / Health Care / Pharmaceuticals
Website
http://scimega.com
About
As Director of Business Development my mission is to attract novel oncology compounds/trials to Canada, and ensure the delivery of tailored Oncology Drug Development solutions throughout North America. Since 2008, I have been involved in conceptualizing and leading Scimega's Reverse Feasibility Program - a novel CRO approach to site selection & patient recruitment - that accelerates study start-up by matching sponsor protocols with the 'real-time' needs of Canada's top oncologists and their patients. I am responsible for developing, launching and executing strategic sales, brand alignment, as well as, inbound marketing campaigns, including: sales tools, product messaging, direct mail, ...
Contact Details
Tags
cancer clinical operations oncology oncology clinical trials clinical oncology patient recruitment clinical research clinical monitoring feasibility study cro internal review boards scimega research pre-qualification visit irb scimega project management canada reverse feasibility site selection study start up oncology investigators pre-qualification visits clinical trial application first-patient in study expansion site enrichment clinical trials personalized medicine investigational new drug application cta
See more
Presentations (5)
See all
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
11 years ago • 1274 Views
Solving the operational challenges of oncology clinical trials
10 years ago • 4614 Views
What Your CRO Doesn't Know Could Hurt You
8 years ago • 1535 Views
AACR Cancer Progress Report 2015
6 years ago • 227 Views
The Secret to Successful Early Phase Study Expansions in Canada
6 years ago • 188 Views
Documents (3)
Canadian CTA vs. U.S. IND
11 years ago • 7636 Views
The Reverse Feasibility Program
11 years ago • 666 Views
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Setting
11 years ago • 829 Views
Likes (1)
What Your CRO Doesn't Know Could Hurt You
Roberto Lara • 8 years ago
Presentations (5)
See all
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
11 years ago • 1274 Views
Solving the operational challenges of oncology clinical trials
10 years ago • 4614 Views
What Your CRO Doesn't Know Could Hurt You
8 years ago • 1535 Views
AACR Cancer Progress Report 2015
6 years ago • 227 Views
The Secret to Successful Early Phase Study Expansions in Canada
6 years ago • 188 Views
Documents (3)
Canadian CTA vs. U.S. IND
11 years ago • 7636 Views
The Reverse Feasibility Program
11 years ago • 666 Views
Oncology Clinical Development Challenges and Opportunities in the Phase 1 Setting
11 years ago • 829 Views
Likes (1)
What Your CRO Doesn't Know Could Hurt You
Roberto Lara • 8 years ago
Personal Information
Organization / Workplace
Montreal, Canada Area Canada
Occupation
Director, Business Development - Oncology
Industry
Medical / Health Care / Pharmaceuticals
Website
http://scimega.com
About
As Director of Business Development my mission is to attract novel oncology compounds/trials to Canada, and ensure the delivery of tailored Oncology Drug Development solutions throughout North America. Since 2008, I have been involved in conceptualizing and leading Scimega's Reverse Feasibility Program - a novel CRO approach to site selection & patient recruitment - that accelerates study start-up by matching sponsor protocols with the 'real-time' needs of Canada's top oncologists and their patients. I am responsible for developing, launching and executing strategic sales, brand alignment, as well as, inbound marketing campaigns, including: sales tools, product messaging, direct mail, ...
Contact Details
Tags
cancer clinical operations oncology oncology clinical trials clinical oncology patient recruitment clinical research clinical monitoring feasibility study cro internal review boards scimega research pre-qualification visit irb scimega project management canada reverse feasibility site selection study start up oncology investigators pre-qualification visits clinical trial application first-patient in study expansion site enrichment clinical trials personalized medicine investigational new drug application cta
See more